Since AAT acts as a plasma protease inhibitor of the enzyme leukocyte elastase (present in neutrophils), AAT deficiency leads to loss of the natural defense mechanisms due to lack of proper protease activities and results in inflammation that triggers emphysema, a common condition observed in COPD patients [27,29]. This evidence concerns the gene SERPINA1 and chronic obstructive pulmonary disease.